期刊文献+

纳米羟基磷灰石/胶原/聚乳酸支架材料对人成骨细胞早期附着影响的实验研究 被引量:9

Adherence of human osteoblast on nHAC/PLA scaffold material
下载PDF
导出
摘要 目的以人成骨细胞(MG-63细胞)复合纳米羟基磷灰石/胶原/聚乳酸[nano-hydroxyapatite/collagen/poly(L-lactic)acid,nHAC/PLA]支架材料进行体外培养,观察其早期附着生长情况。方法将MG-63细胞在nHAC/PLA支架材料上培养,通过倒置显微镜观察、HE染色、ALP染色、细胞增殖指数测定等方法对细胞在nHAC/PLA支架材料上的早期附着情况进行研究。结果细胞在nHAC/PLA上生长良好;ALP染色阳性度高,细胞增殖指数比空白对照组有显著提高。结论nHAC/PLA支架有利于MG-63细胞的早期黏附、生长,可以用作骨组织工程的支架材料。 Objective To study the early adhesion of human osteoblast on nano-hydroxyapatite/collagen/Poly (L-lactic) acid (nHAC/PLA) scaffold material. Methods Human osteoblast were seeded on nHAC/PLA scaffold material and cultured in vitro. The culture process was observed by inverted phase contrast microscope,and HE staining. The alkaline phosphatase (ALP) staining and proliferation index of cells were measured to study the effect of nHAC/PLA scaffold material on human osteoblasts. Results The spreading and proliferation of osteoblast cells throughout the inner- pores of the scaffold material were observed. There was significant difference of the proliferation index of co-cultured ceils, compare to the contral group. Conclusion The nHAC/PLA scaffold material has no effect on the spreading and adherence of MG-63 ceils and it can be used as bone tissue engineering scaffold material.
出处 《生物医学工程与临床》 CAS 2007年第3期161-163,F0003,共4页 Biomedical Engineering and Clinical Medicine
基金 辽宁省教育厅资助项目(05L481)
关键词 纳米羟基磷灰石/胶原/聚乳酸 支架材料 人成骨细胞 nHAC/PLA scaffold material human osteoblast
  • 相关文献

参考文献3

二级参考文献27

  • 1崔福斋,廖素三,关凯,孙天胜.矿化胶原基骨材料与BMP-2复合用于兔腰椎横突间融合[J].生物骨科材料与临床研究,2003,1(1):1-5. 被引量:39
  • 2[1]Sonntag VKH, Marciano FF. Is fusion indicated for lumbar spinal disorders? Spine 1995; 20:138s- 142s
  • 3[2]Boden SD, Schimandle JH, Hutton WC, et al. 1995 Volvo Award in Basic Science: the use of an osteoinductive growth factor for lumbar spinal fusion. Part Ⅰ: biology of spinal fusion.Spine 1995; 20:2626-2632
  • 4[3]Boden SD, Schimandle JH, Hutton WC. 1995 Volvo Award in Basic Science: the use of an osteoinductive growth factor for lumbar spinal fusion. Part Ⅱ: study of dose, carrier, and species.Spine 1995; 20:2633-2644
  • 5[4]Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3:192-195
  • 6[5]Cook SD, Dalton JE, Tan EH, et al. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 1994; 19:1655-1663
  • 7[6]Boden SD, Schimandle JH, Hutton WC. An experimental Lumbar intertransverse process spinal fusion model. Spine 1995a;20:412-420
  • 8[7]Sandhu HS, Kanim MA, Toth JM, et al. Experimental spinal fusion with recombinant human bone morphogenetic protein-2without decortication of osseous elements. Spine 1997; 22:1171-1180
  • 9[8]Lowenstam HA, Weiner S. On biomineralization. New York:Oxford University Press; 1989, p35-40.
  • 10[9]Landis WJ, Song M J, Leith A, et al. Mineral and organic matrix interaction in normally calcifying tendon visualized in three dimensions by high-voltage electron microscopic tomography and graphic image reconstruction. J Struct Bio11993; 110:39-54

共引文献64

同被引文献123

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部